CurrentCignaPolicy N/A

Papzimeos (zopapogene imadenovec) prior authorization for Recurrent Respiratory Papillomatosis

This document is a Cigna prior-authorization request form governing requests for the medication Papzimeos (zopapogene imadenovec) for treatment of Recurrent Respiratory Papillomatosis and other indicated diagnoses; it applies to providers submitting requests to Cigna Pharmacy Services.

Policy Summary

PayerCigna

PolicyPapzimeos prior authorization for Recurrent Respiratory Papillomatosis

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateN/A

Next Review DateN/A

Key ActionComplete the prior authorization form with required patient and prescriber details and attach diagnostic and debulking-procedure documentation.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

5 business daysstandard response time

(800) 882-4462urgent phone

855-840-1678fax

Accredopreferred specialty pharmacy

Coverage Criteria

Initial authorization criteria

Covered when ALL of the following are met

Prerequisite documentation and provider requirements: Patient has confirmed diagnosis of Recurrent Respiratory Papillomatosis by biopsy with supporting medical documentation attached (e.g., chart notes, biopsy report, lab/test results, claims records) including patient identifiers; documentation that the patient has undergone or will undergo a debulking procedure prior to administration is provided; the medication is prescribed by, or in consultation with, a pulmonologist, oncologist, thoracic surgeon, or otolaryngologist; required form fields (patient identifiers, prescriber signature, J‑code, and ICD‑10) are completed.

Form instructions state that medical documentation must be attached or the request may be denied.

The prior‑authorization form does not list any additional exclusionary criteria beyond the items requested on the form. It instead focuses on required fields and supporting documentation to establish medical necessity for Papzimeos (zopapogene imadenovec) for Recurrent Respiratory Papillomatosis; therefore, no explicit exclusions are stated on the form. (Providers should complete all required form fields and attach requested documentation.)

The form indicates that requests lacking required supporting documentation may not be approvable. In particular, requests may be denied if medical documentation confirming the diagnosis by biopsy is not attached, and similarly may be denied if documentation that the patient has or will undergo a debulking procedure prior to administration is not provided. Providers should ensure biopsy confirmation and debulking‑procedure documentation are included with the submission to avoid denial.

Policy Summary

PayerCigna

PolicyPapzimeos prior authorization for Recurrent Respiratory Papillomatosis

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateN/A

Next Review DateN/A

Key ActionComplete the prior authorization form with required patient and prescriber details and attach diagnostic and debulking-procedure documentation.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Provider Actions and Requirements

Prior Authorization

Prior authorization required — complete form with J‑code, ICD‑10, and prescriber/patient details

Prior authorization must be obtained for Papzimeos prior to coverage. Complete the prior authorization form with the requested J‑code and ICD‑10 diagnosis code and include all required patient and prescriber details and supporting documentation as part of the submission.

Form requests entry of J‑Code and ICD10 (see medication section).
Prescriber attestation and signature required on form.

Step Therapy

Infusion setting — use least intensive medically appropriate site

Determine and document the site of infusion; per some Cigna plans the infusion MUST occur in the least intensive medically appropriate setting and the provider should consider redirection to an alternate infusion site, physician's office, or home when clinically appropriate.

Form asks where drug will be administered (home, physician office, hospital outpatient, other).
Note that some plans require least intensive medically appropriate setting and offer Specialty Care Options Case Manager assistance for redirection.

Documentation Required

Diagnosis confirmation required — attach biopsy or equivalent documentation

Attach medical documentation confirming the diagnosis of Recurrent Respiratory Papillomatosis (for example biopsy report, chart notes, laboratory or test results, claims records) with patient identifiers.

Form explicitly asks if diagnosis has been confirmed by biopsy.
Documentation must be specific to your response and include patient‑specific identifying information.

Documentation Required

Debulking procedure documentation — supply chart notes/procedure records

Provide documentation that the patient has undergone or will undergo a debulking procedure prior to administration; include supporting chart notes, procedure records, or other medical documentation with patient identifiers.

Form asks whether documentation is being provided that patient has or will undergo debulking prior to administration.
Documentation must be attached and include patient‑specific identifying information.

Denial Risk

Denial risk — missing diagnostic documentation

Requests may be denied if medical documentation confirming the diagnosis is not attached to the prior authorization request. Ensure biopsy reports or equivalent records with patient identifiers are included to avoid denial.

Form states: “PLEASE NOTE: Medical documentation specific to your response must be attached to this case or your request may be denied.”

Denial Risk

Denial risk — missing debulking procedure documentation

Requests may be denied if documentation that the patient has or will undergo a debulking procedure prior to administration is not provided. Include procedural records or chart notes to support the planned or completed debulking.

Form states: “PLEASE NOTE: Medical documentation specific to your response must be attached to this case or your request may be denied.”

OpenPayer

Papzimeos (zopapogene imadenovec) prior authorization for Recurrent Respiratory Papillomatosis

Coverage Criteria

Billing and Diagnosis Codes

Provider Actions and Requirements

Background

Definitions